143 related articles for article (PubMed ID: 32166592)
1. ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma.
Yu XN; Shen XZ; Guo HY; Zhu JM
Ann Surg Oncol; 2020 May; 27(5):1558-1559. PubMed ID: 32166592
[No Abstract] [Full Text] [Related]
2. Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma.
Yu XN; Zhang GC; Sun JL; Zhu HR; Shi X; Song GQ; Weng SQ; Dong L; Liu TT; Shen XZ; Guo HY; Zhu JM
Ann Surg Oncol; 2020 May; 27(5):1546-1557. PubMed ID: 32157528
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma.
Yang XR; Guo W
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):529-530. PubMed ID: 30519762
[No Abstract] [Full Text] [Related]
4. Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth
Hwang Y; Kim LC; Song W; Edwards DN; Cook RS; Chen J
Cancer Res; 2019 Jul; 79(13):3178-3184. PubMed ID: 31085701
[TBL] [Abstract][Full Text] [Related]
5. ASO Author Reflections: Perioperative Lymphopenia Following Hepatectomy for Hepatocellular Carcinoma: A Routine Yet Overlooked Prognostic Biomarker.
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2024 Apr; 31(4):2604-2605. PubMed ID: 38175426
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma.
Yoh T; Seo S
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):780-781. PubMed ID: 30264250
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Future Perspectives of Novel Prognostic Predictor of Vessels that Encapsulate Tumor Cluster (VETC) for Hepatocellular Carcinoma.
Toshima T; Yoshizumi T; Itoh S; Toshida K; Tomiyama T; Morinaga A; Kosai-Fujimoto Y; Tomino T; Kurihara T; Morita K; Harada N
Ann Surg Oncol; 2021 Dec; 28(13):8196-8197. PubMed ID: 34327602
[No Abstract] [Full Text] [Related]
8. Identifying novel small molecule antagonists for mLST8 protein using computational approaches.
Sapam TD; Velmurugan Ilavarasi A; Palaka BK; Elumalai E; Kanika ND; Ampasala DR
J Recept Signal Transduct Res; 2018 Feb; 38(1):1-11. PubMed ID: 29041842
[TBL] [Abstract][Full Text] [Related]
9. ASO Author Reflections: Liver Transplantation for Hepatocellular Carcinoma.
Wong TCL; Ng KKC
Ann Surg Oncol; 2019 May; 26(5):1463-1464. PubMed ID: 30684160
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: A New Look at the Clinical Significance of MVI in Hepatocellular Carcinoma.
Erstad DJ; Tanabe KK
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):617-618. PubMed ID: 31111348
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Hepatocellular Carcinoma-Related Tumor Necrosis is Associated with Worse Long-Term Outcomes.
Zhang XF; Pawlik TM
Ann Surg Oncol; 2021 Feb; 28(2):806-807. PubMed ID: 33237450
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Identifying Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Chong JU; Choi JS
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):551-552. PubMed ID: 30565038
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Preoperative Hypercoagulability Predicts Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy.
Zhang XP; Cheng SQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):806-807. PubMed ID: 31654157
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma.
Ryu T; Saitsu H
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):808-809. PubMed ID: 31654158
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Salvage Liver Transplant for Recurrent Hepatocellular Carcinoma After Treatments With Curative Intent.
Muaddi H; Sapisochin G
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):794-795. PubMed ID: 30377916
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help?
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2020 Mar; 27(3):875-876. PubMed ID: 31686343
[No Abstract] [Full Text] [Related]
17. Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma.
Lu Y; Li N; Gao L; Xu YJ; Huang C; Yu K; Ling Q; Cheng Q; Chen S; Zhu M; Fang J; Chen M; Ong CN
Cancer Res; 2016 May; 76(10):2912-20. PubMed ID: 26976432
[TBL] [Abstract][Full Text] [Related]
18. ASO Author Reflections: The Role of Postoperative Adjuvant Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Hepatic Vein Invasion.
Zhang XP; Cheng SQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):709-710. PubMed ID: 31468218
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: HCC in LIRADS Lesions-Neither the Exception nor the Rule.
Tang ES; Nanji S
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):762-763. PubMed ID: 31602578
[No Abstract] [Full Text] [Related]
20. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
